Sources | Names Used |
---|---|
GDSC1000 | KIN001-270 |
PharmacoGx | KIN001-270 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ARRDC1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | TREX1 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | OLFM4 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
mRNA | PRKDC | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | SLC9A1 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | RGL2 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | CACNA1D | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | ERAS | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
mRNA | GRIN2C | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | UBXN7 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |